Senior Advisor for Medical and Scientific Affairs of the Elizabeth Glaser Pediatric AIDS Foundation.

Dr. Richard Marlink oversees the Elizabeth Glaser Pediatric AIDS
Foundation’s efforts to expand global HIV/AIDS care and treatment
services, including antiretroviral treatment. Currently a professor at
the Harvard School of Public Health, Dr. Marlink was part of the team
that initially identified HIV-2, the second AIDS virus, and he helped
coordinate research concerning the clinical and biologic characteristics of both HIV-1 and HIV-2. In addition to a number of Botswana clinical studies in which he participates, Dr. Marlink is the principal investigator of Botswana's first large-scale antiretroviral treatment study.